https://healthcarenews.io/news/surgery-center-equipment-maintenance-trimedx-nationwide/Healthcare Newsen2026-11-11T12:25:05.018ZMedicare counted 6,436 surgery centers in 2024. Trimedx now offers them equipment maintenance nationwide https://healthcarenews.io/news/2026-access-to-medicine-index-novartis-ranks-first/Healthcare Newsen2026-11-11T05:36:51.320ZNovartis again leads drugmakers on reaching patients in poorer countries in the 2026 Access to Medicine Index https://healthcarenews.io/news/glanzmann-thrombasthenia-treatment-weekly-injection-phase-3/Healthcare Newsen2026-11-11T02:10:16.867ZGlanzmann thrombasthenia has no approved preventive treatment. A weekly injection enters its final-stage trial https://healthcarenews.io/news/car-t-therapy-for-lupus-without-chemo/Healthcare Newsen2026-11-11T01:40:53.760ZLupus patients reached remission on an off-the-shelf CAR-T given without chemotherapy first, Fate reports https://healthcarenews.io/news/base-editing-for-sickle-cell-disease/Healthcare Newsen2026-11-11T01:17:58.120ZOne-time base editing for sickle cell disease met its goal of a year free of severe crises, Beam says https://healthcarenews.io/news/bioengineered-blood-vessel-for-dialysis-fda-filing/Healthcare Newsen2026-11-11T00:57:09.137ZA lab-grown blood vessel for dialysis patients whose fistulas fail is set for an FDA filing in November https://healthcarenews.io/news/car-t-first-relapse-myeloma-five-year-results/Healthcare Newsen2026-11-11T00:09:41.908ZHalf of myeloma patients given one CAR-T infusion after an early relapse were progression-free five years on https://healthcarenews.io/news/stargardt-disease-clinical-trial-city-rbp4/Healthcare Newsen2026-11-10T23:56:48.476ZStargardt disease has no approved treatment. A new trial tests a shot that limits vitamin A reaching the eye https://healthcarenews.io/news/yutrepia-ph-ild-indication-dropped-patients-keep-therapy/Healthcare Newsen2026-11-10T21:16:41.826ZYutrepia patients with PH-ILD can stay on their inhaler as the indication comes off the label https://healthcarenews.io/news/silevertinib-phase-3-trial-egfr-lung-cancer-brain/Healthcare Newsen2026-11-10T20:48:44.484ZSilevertinib heads for a Phase 3 trial built around lung cancer that has spread to the brain https://healthcarenews.io/news/portable-enteral-feeding-pump-luminoah-series-b/Healthcare Newsen2026-11-10T20:41:01.250ZA pocket-sized tube-feeding pump with FDA clearance gets $25 million to reach more patients at home https://healthcarenews.io/news/maxcyte-akron-bio-acquisition-cell-therapy-reagents/Healthcare Newsen2026-11-10T20:06:00.621ZMaxCyte's $151.8M Akron Bio deal puts cell engineering and the reagents around it under one supplier https://healthcarenews.io/news/ovarian-cancer-blood-test-tu-stroma-stic/Healthcare Newsen2026-11-10T19:13:42.744ZAn ovarian cancer blood test aims at the precancer stage: Tu-Stroma flags lesions surgeons find only by chance https://healthcarenews.io/news/nun-004-phase-2-trial-mnd-placebo-test/Healthcare Newsen2026-11-10T09:24:47.172ZNuNerve's MND drug NUN-004 faces its first placebo-controlled test after early signs of stabilising disease https://healthcarenews.io/news/lead-212-alpha-therapy-nets-fda-talks-2027/Healthcare Newsen2026-11-10T01:42:43.418ZA lead-212 alpha therapy for neuroendocrine tumors heads to FDA end-of-Phase 2 talks in early 2027